tiprankstipranks
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market
RNTX
Rein Therapeutics
RESEARCH TOOLSreports
Want to see RNTX full AI Analyst Report?

Rein Therapeutics (RNTX) Income Statement

1,212 Followers

Rein Therapeutics Income Statement

Last quarter (Q4 2025), Rein Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Rein Therapeutics's net income was $-31.97M. See Rein Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 21.93M$ 65.11M$ 16.28K$ 27.65K$ 26.61K
Depreciation and Amortization
$ 1.00K$ 63.00K$ 119.00$ 169.00$ 121.00
EBITDA
$ -21.93M$ -28.05M$ -15.23K$ -27.48K$ -26.48K
Operating Income
$ -21.93M$ -65.11M$ -16.28K$ -27.65K$ -26.61K
Other Income/Expenses
$ -28.65M$ 800.00K$ 544.00$ 318.00$ 441.00
Pretax Income
$ -50.58M$ -64.31M$ -15.73K$ -27.33K$ -26.16K
Net Income
$ -49.87M$ -62.88M$ -15.73K$ -27.33K$ -26.16K
Per Share Metrics
Basic EPS
$ -1.96$ -3.51$ -3.42$ -6.02$ -5.89
Diluted EPS
$ -1.96$ -3.51$ -3.42$ -6.02$ -5.89
Weighted Average Shares Outstanding
 25.44M 17.94M 4.60M 4.54M 4.44M
Weighted Average Shares Outstanding (Diluted)
 25.44M 17.94M 4.60M 4.54M 4.44M
Currency in USD

Rein Therapeutics Earnings and Revenue History